Objective To estimate the prevalence, types, and sociodemographic and biobehavioral
correlates of antinuclear antibodies (ANAs) in the US. Methods We conducted a cross …

Objective. Growing evidence suggests increasing frequencies of autoimmunity and certain
autoimmune diseases, but findings are limited by the lack of systematic data and evolving …

The aim of this study was to investigate the types and prevalence of disease-specific
antinuclear antibodies (ANAs) and their relationship to rheumatic diseases in the general …

Objective. To determine the range of antinuclear antibodies (ANA) in “healthy” individuals
compared with that in patients with systemic lupus erythematosus (SLE), systemic sclerosis …

Objective Antinuclear antibodies (ANAs) are detected in∼ 18% of females, yet autoimmune
disease develops in only 5–8%. Immunologic differences between ANA‐positive healthy …

Antinuclear antibodies (ANA) are frequently found in healthy populations. To define the
prevalence, pattern, and titer of ANA in different groups of the healthy Mexican population …

Introduction The finding of antinuclear antibody (ANA) positivity in a healthy individual is
usually of unknown significance and in most cases is benign. However, a subset of such …

Background The incidence of autoimmune diseases such as systemic lupus erythematosus,
rheumatoid arthritis, and primary biliary cirrhosis has increased significantly in China …

Objective The spectrum of antinuclear antibodies (ANA s) is changing to include both
nuclear staining as well as cytoplasmic and mitotic cell patterns (CMP s) and accordingly a …

Autoantibodies have been regarded as a serologic hallmark of systemic autoimmune
rheumatic diseases (ARDs) for more than half a century. Two years following the landmark …